Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kira Biotech

Request full access

Australian biotechnology company developing novel immunomodulatory compounds for the treatment of immune system disorders

Brisbane, AustraliaFounded 2019Biotech & Life Sciences

About Kira Biotech

Kirabiotech is a startup operating in the biotechnology sector, leveraging the extensive experience of its management team in pharmaceuticals and business development. The company is led by Michael Grissinger, a seasoned professional with a 22-year career at Johnson & Johnson, where he held various leadership roles in Mergers and Acquisitions, Corporate Development for Pharmaceuticals, and Pharmaceutical Business Development and Licensing. He has a proven track record of leading transactions and teams across diverse deal-types, geographies, and therapeutic disease areas.

The CEO, Dan Baker, is a medical professional with a background in Biology and a medical degree from the University of Pennsylvania. He has a rich experience in clinical development of immunology drugs and has authored multiple publications in the field. His previous roles include Vice President Immunology R&D at Janssen, where he was responsible for clinical development plans for rheumatology products and the overall strategy on portfolio in rheumatology/immunology.

The company's business model is not explicitly stated, but given the backgrounds of the management team, it is likely that Kirabiotech is involved in the development and licensing of biotech and pharmaceutical products. The company's clients would likely be other pharmaceutical companies, healthcare providers, and possibly research institutions. The company would generate revenue through the licensing of its products, partnerships with other companies, and possibly through the sale of its products.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2019
Headquarters
Brisbane, Australia
Employees
4
Open positions
None listed
Dealroom signal
59.8/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B, B2C

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Oct 2019 $20M $80M IP Group —
SPINOUT✓Other financing Jan 2019 $0 — University of Sydney —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Kira Biotech website traffic

Latest recorded traffic for Kira Biotech is 920 monthly website visits, down 42.5% over the last three months. Kira Biotech's team grew 0% over the past year.

Latest monthly visits920 3-month web change-42.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Kira Biotech in the Brisbane ecosystem

Live from Dealroom

The Kira Biotech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • IP Group

Other known investors3 additional known investors

  • University of Sydney
  • IP Group Australia
  • One Ventures
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇦🇺 Australia75%
🇺🇸 United States25%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kira Biotech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kira Biotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.